Kim Leah N, Cordato Dennis, McDougall Alan, Fraser Clare
Department of Neurology, Liverpool Hospital, Liverpool, Australia.
South Western Sydney Clinical School, University of New South Wales, Kensington, Australia.
Neuroophthalmology. 2021 Aug 11;45(6):380-385. doi: 10.1080/01658107.2021.1947324. eCollection 2021.
The Queen Square Screening Test for Visual Deficits (QS test) screens for changes in visual processing. Our pilot study aimed to review the applicability of the QS test in individuals with dementia compared with those with normal cognition. Participants with major and minor neurocognitive disorder scored 50/71 (n=12) and 61/71 (n=10) respectively on the QS test, compared to 65/71 for age-matched healthy controls (n=11). The QS test score correlated with cognitive impairment as measured using the Rowland Universal Dementia Assessment Scale (r = 0.74). The QS test is an affordable and easy bedside screening test for visual processing changes.
女王广场视觉缺陷筛查测试(QS测试)用于筛查视觉处理方面的变化。我们的初步研究旨在评估QS测试在痴呆症患者与认知正常者中的适用性。与年龄匹配的健康对照组(n = 11,QS测试得分为65/71)相比,患有轻度和重度神经认知障碍的参与者在QS测试中的得分分别为50/71(n = 12)和61/71(n = 10)。QS测试得分与使用罗兰通用痴呆评估量表测得的认知障碍相关(r = 0.74)。QS测试是一种经济实惠且易于操作的床边视觉处理变化筛查测试。